Cargando…
RNA sequencing analysis of activated macrophages treated with the anti-HIV ABX464 in intestinal inflammation
RNA-Seq enables the generation of extensive transcriptome information providing the capability to characterize transcripts (including alternative isoforms and polymorphism), to quantify expression and to identify differential regulation in a single experiment. To reveal the capacity of new anti-HIV...
Autores principales: | Manchon, Laurent, Chebli, Karim, Papon, Laura, Paul, Conception, Garcel, Aude, Campos, Noëlie, Scherrer, Didier, Ehrlich, Hartmut, Hahne, Michael, Tazi, Jamal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644369/ https://www.ncbi.nlm.nih.gov/pubmed/29039845 http://dx.doi.org/10.1038/sdata.2017.150 |
Ejemplares similares
-
The Anti-Hiv Candidate Abx464 Dampens Intestinal Inflammation by Triggering Il-22 Production in Activated Macrophages
por: Chebli, Karim, et al.
Publicado: (2017) -
Both anti-inflammatory and antiviral properties of novel drug candidate ABX464 are mediated by modulation of RNA splicing
por: Vautrin, Audrey, et al.
Publicado: (2019) -
ABX464 (Obefazimod) Upregulates miR-124 to Reduce Proinflammatory Markers in Inflammatory Bowel Diseases
por: Apolit, Cécile, et al.
Publicado: (2022) -
Long lasting control of viral rebound with a new drug ABX464 targeting Rev – mediated viral RNA biogenesis
por: Campos, Noëlie, et al.
Publicado: (2015) -
Safety, Pharmacokinetics, and Antiviral Activity of a Novel HIV Antiviral, ABX464, in Treatment-Naive HIV-Infected Subjects in a Phase 2 Randomized, Controlled Study
por: Steens, Jean-Marc, et al.
Publicado: (2017)